FII limit to be increased to 31.5%; QIP issue up to Rs 450 crore
Natco Pharma announced that Foreign Investment Promotion Board (FIPB) has approved both of its Foreign Direct Investment (FDI) related proposals in its 221st Meeting held on 13 July 2015.The two approvals given are for:-
1) Increase of Foreign Investment Limit from 24% to 31.5% of the paid up equity share capital of the company.
2) Issue and Allotment of Eligible Securities to Qualified Institutional Buyers (QIBs) up to Rs.450 crore.
Powered by Capital Market - Live News
